Bispecific antibody fragments with CD20 × CD28 specificity allow effective autologous and allogeneic T-cell activation against malignant cells in peripheral blood and bone marrow cultures from patients with B-cell lineage leukemia and lymphoma
Author:
Martina Brandl,Ludger Große-Hovest,Ernst Holler,Hans-Jochem Kolb,Gundram Jung
Publication:
Experimental Hematology
Copyright © 1999 International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.